R Ben-Ami
Overview
Explore the profile of R Ben-Ami including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
378
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ben-Ami R, Klochendler A, Seidel M, Sido T, Gurel-Gurevich O, Yassour M, et al.
Clin Microbiol Infect
. 2020 Jun;
26(9):1248-1253.
PMID: 32585353
Introduction: Testing for active SARS-CoV-2 infection is a fundamental tool in the public health measures taken to control the COVID-19 pandemic. Because of the overwhelming use of SARS-CoV-2 reverse transcription...
2.
Shasha D, Valinsky L, Hershkowitz Sikron F, Glatman-Freedman A, Mandelboim M, Toledano A, et al.
Clin Microbiol Infect
. 2019 May;
26(1):101-106.
PMID: 31108229
Objectives: The quadrivalent influenza vaccine (QIV) contains two influenza B antigens (one of each B lineage), while the trivalent vaccine (TIV) contains solely one. As a result, a mismatch between...
3.
Katchman E, Ben-Ami R, Savyon M, Chemtob D, Avidor B, Wasserman A, et al.
Clin Microbiol Infect
. 2016 Nov;
23(5):336.e5-336.e8.
PMID: 27876594
Objectives: Outbreaks of HIV infection have been linked to injectable drug abuse, but specific triggers often remain obscure. We report on an outbreak of primary HIV infection among people who...
4.
Brosh-Nissimov T, Ben-Ami R
Clin Microbiol Infect
. 2015 Jul;
21(11):1011-7.
PMID: 26183300
Targeting fluconazole therapy to achieve predefined pharmacodynamic goals has been suggested as a means of optimizing the treatment of patients with candidaemia. However, data regarding species-specific dosing targets are inconclusive....
5.
Ben-Ami R, Rahav G, Elinav H, Kassis I, Shalit I, Gottesman T, et al.
Clin Microbiol Infect
. 2012 Sep;
19(8):752-6.
PMID: 23005038
The emergence of fluconazole-resistant Candida (FRC) is worrisome, but little is known about susceptibility patterns in different nosocomial settings. We prospectively analysed Candida bloodstream isolates in 18 medical centres in...
6.
Isman-Nelkenbaum G, Wolach B, Gavrieli R, Roos D, Sprecher E, Bash E, et al.
Clin Exp Dermatol
. 2011 Jun;
36(7):759-62.
PMID: 21623884
Chronic granulomatous disease (CGD) is a rare congenital immunodeficiency that affects 1 : 250,000 of the population, which is characterized by recurrent bacterial and fungal infections and by granuloma formation....
7.
Adar T, Ben-Ami R, Elstein D, Zimran P, Berliner S, Yedgar S, et al.
Clin Hemorheol Microcirc
. 2008 Nov;
40(2):113-8.
PMID: 19029636
Red blood cell (RBC) aggregation is enhanced in the presence of ongoing inflammation, because of plasma protein effects, especially fibrinogen. Large RBC aggregates, in addition to being a marker of...
8.
Lamaris G, Ben-Ami R, Lewis R, Kontoyiannis D
J Antimicrob Chemother
. 2008 Jun;
62(3):539-42.
PMID: 18544603
Objectives: Voriconazole and posaconazole are effective as both prophylaxis and treatment for invasive aspergillosis (IA) in immunocompromised patients. Hence, it is important to determine whether Aspergillus pre-exposure to voriconazole or...
9.
Ben-Ami R, Lewis R, Kontoyiannis D
Clin Infect Dis
. 2008 Jun;
47(2):226-35.
PMID: 18540822
In addition to their in vitro inhibitory and fungicidal effects, modern antifungal agents interact in vivo with host immune functions involved in defense against fungal pathogens. The nature of such...
10.
Ben-Ami R, Schwaber M, Navon-Venezia S, Schwartz D, Giladi M, Chmelnitsky I, et al.
Clin Infect Dis
. 2006 Mar;
42(7):925-34.
PMID: 16511754
Background: The prevalence of infections caused by extended-spectrum beta -lactamase (ESBL)-producing Enterobacteriaceae is increasing worldwide. The influx of these bacteria into hospitals has major implications for infection-control and empirical treatment...